1-4 of 4
B. Beverloo
Close
Sort by
Journal Articles

First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Adriamycine, Dexamethasone (PAD) Vs VAD as Induction Treatment Prior to High Dose Melphalan (HDM) in Patients with Newly Diagnosed Multiple Myeloma (MM)

P. Sonneveld, B. van der Holt, I. G.H. Schmidt-Wolf, U. Bertsch, L. el Jarari, Hans-Jürgen Salwender, S. Zweegman, E. Vellenga, J. Schubert, I. W. Blau, GSK Jie, B. Beverloo, A. Jauch, D. Hose, R. Schaafsma, M. J. Kersten, M. Delforge, O. de Weerdt, R. van der Griend, P. W. Wijermans, Hans Martin, H. van der Velde, Henk M. Lokhorst, H. Goldschmidt
Journal: Blood
Blood (2008) 112 (11): 653.
https://doi.org/10.1182/blood.V112.11.653.653
Published: 2008
Journal Articles

Gene Expression Profiles for Molecular Classification of Multiple Myeloma in Newly Diagnosed Patients Included in a Prospective, Multicenter, Phase 3 Trial.

A. Broyl, J. Peeters, D. Hose, Y. de Knegt, B. Beverloo, H. Lokhorst, H. Goldschmidt, M. van Duin, P. Sonneveld
Journal: Blood
Blood (2008) 112 (11): 1683.
https://doi.org/10.1182/blood.V112.11.1683.1683
Published: 2008
Journal Articles

Dasatinib (SPRYCEL®) in Children and Adolescents with Relapsed or Refractory Leukemia: Preliminary Results of the CA180018 Phase I/II Study.

Christian M. Zwaan, M.L. den Boer, B. Beverloo, V. van der Velden, A. Countouriotis, L. Strauss, L. Astier, A. Apanovitch, J. Landman-Parker, P. Kearns
Journal: Blood
Blood (2006) 108 (11): 2162.
https://doi.org/10.1182/blood.V108.11.2162.2162
Published: 2006
Journal Articles

Cytogenetics in Pediatric MDS - Data of the EWOG-MDS 98 Study.

K. Michalova, H. B. Beverloo, G. Michaelsen, B. Schlegelberger, J. Harbott, O. A. Haas, G. B. Kerndrup, L. Sainati, E. Bergstraesser, H. Hasle, J. Starý, M. Trebo, M. M. Van den Heuvel-Eibrink, M. Zecca, P. Noellke, A. Fischer, C. M. Niemeyer, D. R. Betts
Journal: Blood
Blood (2005) 106 (11): 4914.
https://doi.org/10.1182/blood.V106.11.4914.4914
Published: 2005